The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Trazodone Hydrochloride (API)-Global Market Insights and Sales Trends 2025
Synopsis
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
The global Trazodone Hydrochloride (API) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Trazodone Hydrochloride (API) in various end use industries. The expanding demands from the Antidepression, Anxiolytic, Hypnotic and Others, are propelling Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Trazodone Hydrochloride (API), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Trazodone Hydrochloride (API) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Trazodone Hydrochloride (API) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Trazodone Hydrochloride (API) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Trazodone Hydrochloride (API) covered in this report include Teva, Angelini, Mylan, Fermion and The Piramal Group, etc.
The global Trazodone Hydrochloride (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Angelini
Mylan
Fermion
The Piramal Group
Global Trazodone Hydrochloride (API) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Trazodone Hydrochloride (API) market, Segment by Type:
Trazodone Hydrochloride (API)
Others
Global Trazodone Hydrochloride (API) market, by Application
Antidepression
Anxiolytic
Hypnotic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Trazodone Hydrochloride (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Trazodone Hydrochloride (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
The global Trazodone Hydrochloride (API) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Trazodone Hydrochloride (API) in various end use industries. The expanding demands from the Antidepression, Anxiolytic, Hypnotic and Others, are propelling Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Trazodone Hydrochloride (API), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Trazodone Hydrochloride (API) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Trazodone Hydrochloride (API) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Trazodone Hydrochloride (API) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Trazodone Hydrochloride (API) covered in this report include Teva, Angelini, Mylan, Fermion and The Piramal Group, etc.
The global Trazodone Hydrochloride (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Angelini
Mylan
Fermion
The Piramal Group
Global Trazodone Hydrochloride (API) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Trazodone Hydrochloride (API) market, Segment by Type:
Trazodone Hydrochloride (API)
Others
Global Trazodone Hydrochloride (API) market, by Application
Antidepression
Anxiolytic
Hypnotic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Trazodone Hydrochloride (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Trazodone Hydrochloride (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Trazodone Hydrochloride (API) Market Overview
1.1 Trazodone Hydrochloride (API) Product Overview
1.2 Trazodone Hydrochloride (API) Market Segment by Type
1.2.1 Trazodone Hydrochloride (API)
1.2.2 Others
1.3 Global Trazodone Hydrochloride (API) Market Size by Type
1.3.1 Global Trazodone Hydrochloride (API) Market Size Overview by Type (2018-2029)
1.3.2 Global Trazodone Hydrochloride (API) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Trazodone Hydrochloride (API) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Trazodone Hydrochloride (API) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Trazodone Hydrochloride (API) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Trazodone Hydrochloride (API) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Trazodone Hydrochloride (API) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Trazodone Hydrochloride (API) Sales Breakdown by Type (2018-2023)
2 Global Trazodone Hydrochloride (API) Market Competition by Company
2.1 Global Top Players by Trazodone Hydrochloride (API) Sales (2018-2023)
2.2 Global Top Players by Trazodone Hydrochloride (API) Revenue (2018-2023)
2.3 Global Top Players by Trazodone Hydrochloride (API) Price (2018-2023)
2.4 Global Top Manufacturers Trazodone Hydrochloride (API) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Trazodone Hydrochloride (API) Market Competitive Situation and Trends
2.5.1 Trazodone Hydrochloride (API) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Trazodone Hydrochloride (API) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Trazodone Hydrochloride (API) as of 2022)
2.7 Date of Key Manufacturers Enter into Trazodone Hydrochloride (API) Market
2.8 Key Manufacturers Trazodone Hydrochloride (API) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Trazodone Hydrochloride (API) Status and Outlook by Region
3.1 Global Trazodone Hydrochloride (API) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Trazodone Hydrochloride (API) Historic Market Size by Region
3.2.1 Global Trazodone Hydrochloride (API) Sales in Volume by Region (2018-2023)
3.2.2 Global Trazodone Hydrochloride (API) Sales in Value by Region (2018-2023)
3.2.3 Global Trazodone Hydrochloride (API) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Trazodone Hydrochloride (API) Forecasted Market Size by Region
3.3.1 Global Trazodone Hydrochloride (API) Sales in Volume by Region (2024-2029)
3.3.2 Global Trazodone Hydrochloride (API) Sales in Value by Region (2024-2029)
3.3.3 Global Trazodone Hydrochloride (API) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Trazodone Hydrochloride (API) by Application
4.1 Trazodone Hydrochloride (API) Market Segment by Application
4.1.1 Antidepression
4.1.2 Anxiolytic
4.1.3 Hypnotic
4.1.4 Others
4.2 Global Trazodone Hydrochloride (API) Market Size by Application
4.2.1 Global Trazodone Hydrochloride (API) Market Size Overview by Application (2018-2029)
4.2.2 Global Trazodone Hydrochloride (API) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Trazodone Hydrochloride (API) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Trazodone Hydrochloride (API) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Trazodone Hydrochloride (API) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Trazodone Hydrochloride (API) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Trazodone Hydrochloride (API) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Trazodone Hydrochloride (API) Sales Breakdown by Application (2018-2023)
5 North America Trazodone Hydrochloride (API) by Country
5.1 North America Trazodone Hydrochloride (API) Historic Market Size by Country
5.1.1 North America Trazodone Hydrochloride (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Trazodone Hydrochloride (API) Sales in Volume by Country (2018-2023)
5.1.3 North America Trazodone Hydrochloride (API) Sales in Value by Country (2018-2023)
5.2 North America Trazodone Hydrochloride (API) Forecasted Market Size by Country
5.2.1 North America Trazodone Hydrochloride (API) Sales in Volume by Country (2024-2029)
5.2.2 North America Trazodone Hydrochloride (API) Sales in Value by Country (2024-2029)
6 Europe Trazodone Hydrochloride (API) by Country
6.1 Europe Trazodone Hydrochloride (API) Historic Market Size by Country
6.1.1 Europe Trazodone Hydrochloride (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Trazodone Hydrochloride (API) Sales in Volume by Country (2018-2023)
6.1.3 Europe Trazodone Hydrochloride (API) Sales in Value by Country (2018-2023)
6.2 Europe Trazodone Hydrochloride (API) Forecasted Market Size by Country
6.2.1 Europe Trazodone Hydrochloride (API) Sales in Volume by Country (2024-2029)
6.2.2 Europe Trazodone Hydrochloride (API) Sales in Value by Country (2024-2029)
7 Asia-Pacific Trazodone Hydrochloride (API) by Region
7.1 Asia-Pacific Trazodone Hydrochloride (API) Historic Market Size by Region
7.1.1 Asia-Pacific Trazodone Hydrochloride (API) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Trazodone Hydrochloride (API) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Trazodone Hydrochloride (API) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Trazodone Hydrochloride (API) Forecasted Market Size by Region
7.2.1 Asia-Pacific Trazodone Hydrochloride (API) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Trazodone Hydrochloride (API) Sales in Value by Region (2024-2029)
8 Latin America Trazodone Hydrochloride (API) by Country
8.1 Latin America Trazodone Hydrochloride (API) Historic Market Size by Country
8.1.1 Latin America Trazodone Hydrochloride (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Trazodone Hydrochloride (API) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Trazodone Hydrochloride (API) Sales in Value by Country (2018-2023)
8.2 Latin America Trazodone Hydrochloride (API) Forecasted Market Size by Country
8.2.1 Latin America Trazodone Hydrochloride (API) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Trazodone Hydrochloride (API) Sales in Value by Country (2024-2029)
9 Middle East and Africa Trazodone Hydrochloride (API) by Country
9.1 Middle East and Africa Trazodone Hydrochloride (API) Historic Market Size by Country
9.1.1 Middle East and Africa Trazodone Hydrochloride (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Trazodone Hydrochloride (API) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Trazodone Hydrochloride (API) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Trazodone Hydrochloride (API) Forecasted Market Size by Country
9.2.1 Middle East and Africa Trazodone Hydrochloride (API) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Trazodone Hydrochloride (API) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Trazodone Hydrochloride (API) Products Offered
10.1.5 Teva Recent Development
10.2 Angelini
10.2.1 Angelini Company Information
10.2.2 Angelini Introduction and Business Overview
10.2.3 Angelini Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Angelini Trazodone Hydrochloride (API) Products Offered
10.2.5 Angelini Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Trazodone Hydrochloride (API) Products Offered
10.3.5 Mylan Recent Development
10.4 Fermion
10.4.1 Fermion Company Information
10.4.2 Fermion Introduction and Business Overview
10.4.3 Fermion Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Fermion Trazodone Hydrochloride (API) Products Offered
10.4.5 Fermion Recent Development
10.5 The Piramal Group
10.5.1 The Piramal Group Company Information
10.5.2 The Piramal Group Introduction and Business Overview
10.5.3 The Piramal Group Trazodone Hydrochloride (API) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 The Piramal Group Trazodone Hydrochloride (API) Products Offered
10.5.5 The Piramal Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Trazodone Hydrochloride (API) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Trazodone Hydrochloride (API) Industrial Chain Analysis
11.4 Trazodone Hydrochloride (API) Market Dynamics
11.4.1 Trazodone Hydrochloride (API) Industry Trends
11.4.2 Trazodone Hydrochloride (API) Market Drivers
11.4.3 Trazodone Hydrochloride (API) Market Challenges
11.4.4 Trazodone Hydrochloride (API) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Trazodone Hydrochloride (API) Distributors
12.3 Trazodone Hydrochloride (API) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
